Inova Schar Cancer Center
Inova Schar Cancer Center
Fairfax, Virginia, United States2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer | Ear Diseases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, carcinoma, epithelial neoplasm, head and neck cancer, hearing disorder, hearing loss disorder, neoplasm, nervous system disorder, otorhinolaryngologic disease, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2026-09-02 | NCT04915183 | |
| First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 1 | 2025-09-22 | NCT05216432 |